Exploring species-level infant gut bacterial biodiversity by meta-analysis and formulation of an optimized cultivation medium

被引:18
作者
Alessandri, Giulia [1 ]
Fontana, Federico [2 ]
Mancabelli, Leonardo [1 ]
Lugli, Gabriele Andrea [1 ]
Tarracchini, Chiara [1 ]
Argentini, Chiara [1 ]
Longhi, Giulia [2 ]
Viappiani, Alice [2 ]
Milani, Christian [1 ,3 ]
Turroni, Francesca [1 ,3 ]
van Sinderen, Douwe [4 ,5 ]
Ventura, Marco [1 ,3 ]
机构
[1] Univ Parma, Dept Chem Environm Sustainabil, Lab Probiogen, Parma, Italy
[2] GenProbio Srl, Parma, Italy
[3] Univ Parma, Microbiome Res Hub, Parma, Italy
[4] Natl Univ Ireland, APC Microbiome Inst, Cork, Ireland
[5] Natl Univ Ireland, Sch Microbiol, Biosci Inst, Cork, Ireland
基金
爱尔兰科学基金会;
关键词
MICROBIOME; BIFIDOBACTERIUM; MUCIN; STRATEGIES; STABILITY; HEALTH; IMPACT;
D O I
10.1038/s41522-022-00349-1
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
In vitro gut cultivation models provide host-uncoupled, fast, and cost-efficient solutions to investigate the effects of intrinsic and extrinsic factors impacting on both composition and functionality of the intestinal microbial ecosystem. However, to ensure the maintenance and survival of gut microbial players and preserve their functions, these systems require close monitoring of several variables, including oxygen concentration, pH, and temperature, as well as the use of a culture medium satisfying the microbial nutritional requirements. In this context, in order to identify the macro- and micro-nutrients necessary for in vitro cultivation of the infant gut microbiota, a meta-analysis based on 1669 publicly available shotgun metagenomic samples corresponding to fecal samples of healthy, full-term infants aged from a few days to three years was performed to define the predominant species characterizing the "infant-like" gut microbial ecosystem. A subsequent comparison of growth performances was made using infant fecal samples that contained the most abundant bacterial taxa of the infant gut microbiota, when cultivated on 18 different culture media. This growth analysis was performed by means of flow cytometry-based bacterial cell enumeration and shallow shotgun sequencing, which allowed the formulation of an optimized growth medium, i.e., Infant Gut Super Medium (IGSM), which maintains and sustains the infant gut microbial biodiversity under in vitro growth conditions. Furthermore, this formulation was used to evaluate the in vitro effect of two drugs commonly used in pediatrics, i.e., acetaminophen and simethicone, on the taxonomic composition of the infant gut microbiota.
引用
收藏
页数:12
相关论文
共 83 条
  • [51] Reporting guidelines for human microbiome research: the STORMS checklist
    Mirzayi, Chloe
    Renson, Audrey
    Zohra, Fatima
    Elsafoury, Shaimaa
    Geistlinger, Ludwig
    Kasselman, Lora J.
    Eckenrode, Kelly
    van de Wijgert, Janneke
    Loughman, Amy
    Marques, Francine Z.
    MacIntyre, David A.
    Arumugam, Manimozhiyan
    Azhar, Rimsha
    Beghini, Francesco
    Bergstrom, Kirk
    Bhatt, Ami
    Bisanz, Jordan E.
    Braun, Jonathan
    Bravo, Hector Corrada
    Buck, Gregory A.
    Bushman, Frederic
    Casero, David
    Clarke, Gerard
    Carmen Collado, Maria
    Cotter, Paul D.
    Cryan, John F.
    Demmer, Ryan T.
    Devkota, Suzanne
    Elinav, Eran
    Escobar, Juan S.
    Fettweis, Jennifer
    Finn, Robert D.
    Fodor, Anthony A.
    Forslund, Sofia
    Franke, Andre
    Furlanello, Cesare
    Gilbert, Jack
    Grice, Elizabeth
    Haibe-Kains, Benjamin
    Handley, Scott
    Herd, Pamela
    Holmes, Susan
    Jacobs, Jonathan P.
    Karstens, Lisa
    Knight, Rob
    Knights, Dan
    Koren, Omry
    Kwon, Douglas S.
    Langille, Morgan
    Lindsay, Brianna
    [J]. NATURE MEDICINE, 2021, 27 (11) : 1885 - 1892
  • [52] Bifidobacterial inulin-type fructan degradation capacity determines cross-feeding interactions between bifidobacteria and Faecalibacterium prausnitzii
    Moens, Frederic
    Weckx, Stefan
    De Vuyst, Luc
    [J]. INTERNATIONAL JOURNAL OF FOOD MICROBIOLOGY, 2016, 231 : 76 - 85
  • [53] The infant microbiome development: mom matters
    Mueller, Noel T.
    Bakacs, Elizabeth
    Combellick, Joan
    Grigoryan, Zoya
    Dominguez-Bello, Maria G.
    [J]. TRENDS IN MOLECULAR MEDICINE, 2015, 21 (02) : 109 - 117
  • [54] Butyrate Levels in the Transition from an Infant- to an Adult-Like Gut Microbiota Correlate with Bacterial Networks Associated with Eubacterium Rectale and Ruminococcus Gnavus
    Nilsen, Morten
    Madelen Saunders, Carina
    Leena Angell, Inga
    Arntzen, Magnus O.
    Lodrup Carlsen, Karin C.
    Carlsen, Kai-Hakon
    Haugen, Guttorm
    Heldal Hagen, Live
    Carlsen, Monica H.
    Hedlin, Gunilla
    Monceyron Jonassen, Christine
    Nordlund, Bjorn
    Maria Rehbinder, Eva
    Skjerven, Havard O.
    Snipen, Lars
    Cathrine Staff, Anne
    Vettukattil, Riyas
    Rudi, Knut
    [J]. GENES, 2020, 11 (11) : 1 - 15
  • [55] Bifidobacteria and Their Role as Members of the Human Gut Microbiota
    O'Callaghan, Amy
    van Sinderen, Douwe
    [J]. FRONTIERS IN MICROBIOLOGY, 2016, 7
  • [56] Extensive Unexplored Human Microbiome Diversity Revealed by Over 150,000 Genomes from Metagenomes Spanning Age, Geography, and Lifestyle
    Pasolli, Edoardo
    Asnicar, Francesco
    Manara, Serena
    Zolfo, Moreno
    Karcher, Nicolai
    Armanini, Federica
    Beghini, Francesco
    Manghi, Paolo
    Tett, Adrian
    Ghensi, Paolo
    Carmen Collado, Maria
    Rice, Benjamin L.
    DuLong, Casey
    Morgan, Xochitl C.
    Golden, Christopher D.
    Quince, Christopher
    Huttenhower, Curtis
    Segata, Nicola
    [J]. CELL, 2019, 176 (03) : 649 - +
  • [57] Advances and perspectives in in vitro human gut fermentation modeling
    Payne, Amanda N.
    Zihler, Annina
    Chassard, Christophe
    Lacroix, Christophe
    [J]. TRENDS IN BIOTECHNOLOGY, 2012, 30 (01) : 17 - 25
  • [58] Pham VT, 2018, BENEF MICROBES, V9, P725, DOI [10.3920/BM2017.0164, 10.3920/bm2017.0164]
  • [59] Effects of a nine-strain bacterial synbiotic compared to simethicone in colicky babies - an open-label randomised study
    Piatek, J.
    Bernatek, M.
    Krauss, H.
    Wojciechowska, M.
    Checinska-Maciejewska, Z.
    Kaczmarek, P.
    Sommermeyer, H.
    [J]. BENEFICIAL MICROBES, 2021, 12 (03) : 249 - 257
  • [60] Fragment-based drug discovery and its application to challenging drug targets
    Price, Amanda J.
    Howard, Steven
    Cons, Benjamin D.
    [J]. STRUCTURE-BASED DRUG DESIGN: INSIGHTS FROM ACADEMIA AND INDUSTRY, 2017, 61 (05): : 475 - 484